- Previous Close
19.05 - Open
19.16 - Bid 19.18 x 1000
- Ask 19.38 x 1000
- Day's Range
18.99 - 19.35 - 52 Week Range
10.24 - 26.30 - Volume
738,141 - Avg. Volume
1,822,583 - Market Cap (intraday)
4.631B - Beta (5Y Monthly) 1.44
- PE Ratio (TTM)
-- - EPS (TTM)
-1.35 - Earnings Date May 14, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
27.57
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to access, collect, review, extract, decode, decrypt, analyze, share, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Endpoint Mobile Now; and professional services, such as training and certification services, and advanced services. It serves federal and state and local agencies. The company is headquartered in Petah Tikva, Israel.
www.cellebrite.com1,167
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: CLBT
View MorePerformance Overview: CLBT
Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CLBT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CLBT
View MoreValuation Measures
Market Cap
4.56B
Enterprise Value
4.13B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.95
Price/Book (mrq)
13.58
Enterprise Value/Revenue
10.28
Enterprise Value/EBITDA
61.11
Financial Highlights
Profitability and Income Statement
Profit Margin
-70.54%
Return on Assets (ttm)
5.81%
Return on Equity (ttm)
-152.88%
Revenue (ttm)
401.2M
Net Income Avi to Common (ttm)
-283.01M
Diluted EPS (ttm)
-1.35
Balance Sheet and Cash Flow
Total Cash (mrq)
447.22M
Total Debt/Equity (mrq)
3.26%
Levered Free Cash Flow (ttm)
107.45M